North American Graves' disease Market Industry Updates, Future Growth, Business Prospects and Forthcoming Developments Forecast to 2025

North American Graves' disease market is growing at a CAGR of around 4.3% during the forecast period. North American Grave's disease market has been primarily driven by increasing prevalence of thyroid disorders, and significant awareness about thyroid treatment and diagnosis. Moreover, some initiatives to support Americans suffering from thyroid disease are also contributing to the growth of the North American Graves' disease market. For instance, in January 2016, AmeriCares supported thousands of Americans suffering from thyroid disease in terms of providing medication. This donation was conducted in recognition of Thyroid Awareness Month. This will enable health and emergency response organizations to offer levothyroxine therapy for an average 25,000 underinsured, insured, and low-income patients of community health centers and clinics nationwide.

Get Sample Copy of North American Graves' disease Market at: https://www.omrglobal.com/request-sample/north-american-graves-disease-market

Key Players - Abbott Laboratories Inc., Allergan PLC, Eli Lilly and Co., GlaxoSmithKline PLC, Johnson & Johnson, Macleods Pharmaceuticals Ltd., Merck & Co. Inc., Mylan NV, Novartis International AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd.

According to the American Thyroid Association, approximately 20 million people all over the US have some kind of thyroid disorders. Several patients require medication to control the functioning of the thyroid and needs treatment for life. Akrimax Pharmaceuticals, LLC, located in Cranford, New Jersey, US is a key sponsor of the thyroid month campaign. The company donated $2.4 million worth of levothyroxine therapy. This is sufficient to meet monthly prescriptions for approximately 25,000 patients.

For More Information, get A full report of North American Graves' disease Market is available at: https://www.omrglobal.com/industry-reports/north-american-graves-disease-market

Due to significant rise in the prevalence of thyroid disorders, the increasing number of smokers, the considerable population suffering from type-1 diabetes and launching of thyroid awareness programs by pharmaceutical companies in North America. The North American Graves' disease market has been estimated to grow at a CAGR of 4.3% during the forecast period of 2018-2023. The US is the leading shareholder in the North American Grave's diseases market. Substantial funding for R&D activities in the US is also contributing towards the North American Graves' disease during the forecast period.

Market Segmentation

Graves' Disease Market by Diagnosis

o Ultrasound
o Imaging Tests
o Radioactive Iodine Uptake
o Blood Sample

Graves' Disease Market by Treatment

o Anti- Thyroid Medication
o Radioactive Iodine Therapy
o Surgery

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/north-american-graves-disease-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.